NMRA - Neumora Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NMRA (1885522)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
23 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2024-10-17
NMRAFust Matthew KDirS - Sale+OE$17.03-21,78820,100-52%-$370,962
M
2024-10-09
NMRALenz Robert A.Head of R, DS - Sale$15.06-13,823314,706-4%-$208,110
M
2024-09-17
NMRALenz Robert A.Head of R, DS - Sale$11.89-41,464328,529-11%-$492,827
2024-09-12
NMRALenz Robert A.Head of R, DS - Sale$11.43-32,948369,993-8%-$376,665
2024-08-27
NMRAPinto JoshuaCFOS - Sale$11.39-15,693223,965-7%-$178,806
M
2024-08-22
NMRAPinto JoshuaCFOS - Sale$11.67-84,307239,658-26%-$984,061
M
2023-11-13
NMRABurow KristinaDir, 10%P - Purchase$11.77+35,0104,144,827+1%+$412,140
M
2023-11-13
NMRAArch Venture Partners Xii, LLC10%P - Purchase$11.77+35,0104,131,207+1%+$412,140
M
2023-11-08
NMRABurow KristinaDir, 10%P - Purchase$10.98+140,6054,109,817+4%+$1,543,563
M
2023-11-08
NMRAArch Venture Partners Xii, LLC10%P - Purchase$10.98+140,6054,096,197+4%+$1,543,563
M
2023-11-03
NMRABurow KristinaDir, 10%P - Purchase$11.49+95,6943,969,212+2%+$1,099,945
M
2023-11-03
NMRAArch Venture Partners Xii, LLC10%P - Purchase$11.49+95,6943,955,592+2%+$1,099,945
M
2023-09-28
NMRABurow KristinaDir, 10%P - Purchase$13.68+76,5113,873,518+2%+$1,046,848
M
2023-09-28
NMRAArch Venture Partners Xii, LLC10%P - Purchase$13.68+76,5113,859,898+2%+$1,046,848
M
2023-09-26
NMRABurow KristinaDir, 10%P - Purchase$11.97+58,5043,797,007+2%+$700,464
M
2023-09-26
NMRAArch Venture Partners Xii, LLC10%P - Purchase$11.97+58,5043,783,387+2%+$700,464
M
2023-09-22
NMRAArch Venture Partners Xii, LLC10%P - Purchase$11.19+100,7403,724,883+3%+$1,127,064
M
2023-09-22
NMRABurow KristinaDir, 10%P - Purchase$11.19+100,7403,738,503+3%+$1,127,064
D
2023-09-19
NMRABurow KristinaDir, 10%P - Purchase$17.00+1,500,00015,524,521+11%+$25,500,000
D
2023-09-19
NMRAArch Venture Partners X, LLC10%P - Purchase$17.00+1,500,00029,545,420+5%+$25,500,000
D
2023-09-19
NMRAArch Venture Partners X, LLC10%P - Purchase$17.00+1,500,00029,545,420+5%+$25,500,000
2023-09-19
NMRAGosebruch Henry OPres, CEOP - Purchase$12.62+15,000524,793+3%+$189,371
D
2023-09-19
NMRAAmgen Inc10%P - Purchase$17.00+1,764,70535,368,653+5%+$29,999,985

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top